Impact of Maternal HIV Seroconversion during Pregnancy on Early Mother to Child Transmission of HIV (MTCT) Measured at 4-8 Weeks Postpartum in South Africa 2011-2012: A National Population-Based Evaluation-Reference-Cited by-同舟云学术

Impact of Maternal HIV Seroconversion during Pregnancy on Early Mother to Child Transmission of HIV (MTCT) Measured at 4-8 Weeks Postpartum in South Africa 2011-2012: A National Population-Based Evaluation

Published:2015-05-05 Issue:5 Volume:10 Page:e0125525
ISSN:1932-6203
Container-title:PLOS ONE
language:en
Short-container-title:PLoS ONE

Author:

Dinh Thu-Ha,Delaney Kevin P.,Goga Ameena,Jackson Debra,Lombard Carl,Woldesenbet Selamawit,Mogashoa Mary,Pillay Yogan,Shaffer Nathan

Publisher

Public Library of Science (PLoS)

Subject

Multidisciplinary

Reference30 articles.

1. National Department of Health of South Africa, SANAC. CLINICAL GUIDELINES: PMTCT (Prevention of Mother-to-Child Transmission). 2010.

2. World Health Organization2013 [cited 2013 July 15]. Consolidated guidelines on the use of antiretroviral drugs for treating and preventing HIV infection]. Available from: http://www.who.int/hiv/pub/guidelines/arv2013/en/index.html.

3. Maternal or Infant Antiretroviral Drugs to Reduce HIV-1 Transmission;CS Chasela;New England Journal of Medicine,2010

4. Triple antiretroviral compared with zidovudine and single-dose nevirapine prophylaxis during pregnancy and breastfeeding for prevention of mother-to-child transmission of HIV-1 (Kesho Bora study): a randomised controlled trial;I de Vincenzi;The Lancet Infectious Diseases,2011

5. In the Vertical Transmission of HIV, Timing May Be Everything;PA Pizzo;New England Journal of Medicine,1991

Cited by 98 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Safety and pharmacokinetics of subcutaneous administration of broadly neutralizing anti-HIV-1 monoclonal antibodies (bNAbs), given to HIV-1 exposed, uninfected neonates and infants: study protocol for a phase I trial;BMC Infectious Diseases;2024-07-20

2. Safety and pharmacokinetics of subcutaneous administration of broadly neutralizing anti-HIV-1 monoclonal antibodies (bNAbs), given to HIV-1 exposed, uninfected neonates and infants: study protocol for a phase I trial Acronym: PedMAb1;2024-07-19

3. Barriers and facilitators to uptake and use of oral pre-exposure prophylaxis in pregnant and postpartum women: a qualitative meta-synthesis;BMC Public Health;2024-06-20

4. HIV seroconversion and associated factors among seronegative pregnant women attending ANC in Ethiopia: an institution-based cross-sectional study;Frontiers in Reproductive Health;2024-04-10

5. Randomized Trial of Dynamic Choice HIV Prevention at Antenatal and Postnatal Care Clinics in Rural Uganda and Kenya;JAIDS Journal of Acquired Immune Deficiency Syndromes;2024-03-11